Outside News Sources
Publish Date Headline
Oct 6, 2014 Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia
Sep 9, 2014 Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma
Sep 4, 2014 Sunesis to Present at the 2014 Morgan Stanley Global Healthcare Conference
Aug 6, 2014 Sunesis to Present at the 2014 Wedbush Life Sciences Management Access Conference
Aug 5, 2014 Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights
Jul 29, 2014 Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 Financial Results and Recent Highlights
Jul 9, 2014 Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo(TM) (Vosaroxin) for AML
